GMP Validation - Lipoaspiration

  • Research type

    Research Study

  • Full title

    Lipoaspirate procurement from Volunteers - Cambridge to Galway for good manufacture practice (GMP) validation

  • IRAS ID

    200226

  • Contact name

    Andrew McCaskie

  • Contact email

    awm41@cam.ac.uk

  • Sponsor organisation

    Cambridge University Hospitals NHS Foundation Trust and University of Cambridge

  • Duration of Study in the UK

    0 years, 3 months, 29 days

  • Research summary

    The aim of this study is to validate processes surrounding the procurement of adipose (fat) tissue in Cambridge from the waste product of patients undergoing lipoaspiration.

    This lipoaspirate will be used for the validation of the transport and production processes of Adipose derived stem cells between Cambridge UK and the production centre in Galway Ireland.

    The Cell product will be produced in Galway at The Centre for Cell Manufacturing Ireland (CCMI) National University of Ireland Galway. The cell product from this feasibility study will be returned to Cambridge but will not be used on patient and will be destroyed.

    This is in preparation for the ADIPOA2 (www.adipoa2.eu) Trial due start in 2016.

  • REC name

    East of England - Cambridgeshire and Hertfordshire Research Ethics Committee

  • REC reference

    16/EE/0257

  • Date of REC Opinion

    5 Aug 2016

  • REC opinion

    Further Information Favourable Opinion